the Company’s lack of revenue to date, current and planned operating business;

the magnitude of the share issuances following the Company’s reverse stock split on April 9, 2012, under which the Company’s number of total shares outstanding (“TSO”) rose from 1.56 million on May 11, 2012 to 4.3 million by January 7, 2013 and was expected to continue to grow;

the lack of oversight by the Company’s prior Interim Chief Executive Officer with respect to the Company’s operations, especially given that, during his tenure as Chief Executive Officer, Mr. Lacey certified each of the Company’s periodic reports filed with the SEC as to their accuracy and completeness, as required by the Sarbanes- Oxley Act of 2002, taken together with the staff’s concerns regarding the Company’s current limited business activity, and the concern about shareholder approval violations;

the Company’s ability to continue to comply with Nasdaq’s listing standards given that in its Form 10-Q for the period ended September 30, 2012, the Company reported stockholders’ equity of $2,663,519, since its inception, the Company has incurred losses, including a $3.8 million loss for the nine months ended September 30, 2012 and losses of $3.4 million and $28.1 million for the years ended December 31, 2011 and 2010, and that the Company’s CFO advised the staff that it expects to report stockholders’ equity below the minimum $2.5 million requirement for continued listing on The Nasdaq Capital Market, as prescribed in Listing Rule 5550(b)(1) when it files its Annual Report on Form 10-K for the year ended December 31, 2012;

the history of the Company’s non-compliance with the Listing Rules, having received notifications for failure to evidence compliance on thirteen (13) separate occasions, ten (10) of those occurring within the past three and a half years, including minimum bid price in September 2009 and April 2011; the periodic filing obligation in November 2012; minimum stockholders’ equity in November 2010; the shareholder approval rules with respect to equity compensation and private placements in November 2010; annual meeting of shareholders in January 2010 and January 2013; majority independent board of directors in November 2011; and audit committee composition in May 2010 and November 2011;

whether 200,000 shares of restricted common stock issued to Brendan MacMillan should have required shareholder approval; and

whether 185,717 shares issued to five employees as inducement compensation in November 2012, 1,034,001 shares issued to nine employees as inducement compensation in December 2012 and 239,000 shares issued to three individuals as compensation for consulting work in December 2012 required shareholder approval.